Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Common Equity (2022 - 2025)

Medinotec filings provide 4 years of Common Equity readings, the most recent being $5.5 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 94.64% to $5.5 million in Q4 2025 year-over-year; TTM through Nov 2025 was $5.5 million, a 94.64% increase, with the full-year FY2025 number at $4.3 million, up 97.07% from a year prior.
  • Common Equity hit $5.5 million in Q4 2025 for Medinotec, up from $4.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.5 million in Q4 2025 to a low of -$729826.0 in Q3 2022.
  • Median Common Equity over the past 4 years was $2.6 million (2022), compared with a mean of $2.7 million.
  • The widest YoY moves for Common Equity: up 643.86% in 2023, down 19.7% in 2023.
  • Medinotec's Common Equity stood at $2.6 million in 2022, then fell by 19.7% to $2.1 million in 2023, then skyrocketed by 36.17% to $2.8 million in 2024, then skyrocketed by 94.64% to $5.5 million in 2025.
  • The last three reported values for Common Equity were $5.5 million (Q4 2025), $4.8 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.